Roberta Minari et. al, Concurrent acquired BRAF V600E mutation and MET amplification as resistance mechanism of first-line osimertinib treatment in NSCLC EGFR-mutated patient.
Lorena Gurrieri et. al, MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme”
Fabrizio Tabbò et. al, Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma
RAS testing for colorectal cancer patients is reliable in European laboratories that pass external quality assessment
Elena Bonaparte et. al, Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry
Intratumoural heterogeneity may hinder precision medicine strategies in patients with clear cell renal cell carcinoma
M. Rosaria Raspollini et.al, Intratumoural heterogeneity may hinder precision medicine strategies in patients with clear cell renal cell carcinoma
Thibaut Kritter et. al, Radiomic Biomarkers Helps to Better Predict Progression Free Survival of Gliomas
